Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R P Perng

Showing results (151-160 of 157) with videos related to

Pageof 16
Sort By:
You have reached the last page of results.This site can display upto 157 results.
American Journal of Clinical Oncology|February 22, 2000
A phase II trial of tamoxifen, ifosfamide, epirubicin, and cisplatin combination chemotherapy for inoperable non-small-cell lung cancerY M Chen, R P Perng, K Y Yang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 29, 1998
Presence of serum anti-p53 antibodies is associated with pleural effusion and poor prognosis in lung cancer patientsC L Lai, C M Tsai, T T Tsai, et al.
Zhonghua Yi Xue Za Zhi = Chinese Medical Journal; Free China Ed|August 12, 1998
Ifosfamide-based chemotherapy for previously treated lung cancer patientsY M Chen, J M Liu, M F Wu, et al.
Japanese Journal of Clinical Oncology|April 1, 1997
Phase II study of ifosfamide and etoposide chemotherapy for extensive-disease small-cell lung cancerY M Chen, M F Wu, R P Perng, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|October 23, 1997
Restoration of the immunocompetence by IL-2 activation and TCR-CD3 engagement of the in vivo anergized tumor-specific CTL from lung cancer patientsY M Chen, W K Yang, J Whang-Peng, et al.
American Journal of Clinical Oncology|February 22, 2000
A phase II trial of vinorelbine and cisplatin in previously untreated inoperable non--small-cell lung cancerR P Perng, J F Shih, Y M Chen, et al.
British Journal of Cancer|March 1, 2002
Gemcitabine and cisplatin in a multimodality treatment for locally advanced non-small cell lung cancerC H Yang, C M Tsai, L S Wang, et al.
Pageof 16

Showing results (151-160 of 157) with videos related to

Sort By:
Pageof 16
You have reached the last page of results.This site can display upto 157 results.
American Journal of Clinical Oncology|February 22, 2000
A phase II trial of tamoxifen, ifosfamide, epirubicin, and cisplatin combination chemotherapy for inoperable non-small-cell lung cancerY M Chen, R P Perng, K Y Yang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 29, 1998
Presence of serum anti-p53 antibodies is associated with pleural effusion and poor prognosis in lung cancer patientsC L Lai, C M Tsai, T T Tsai, et al.
Zhonghua Yi Xue Za Zhi = Chinese Medical Journal; Free China Ed|August 12, 1998
Ifosfamide-based chemotherapy for previously treated lung cancer patientsY M Chen, J M Liu, M F Wu, et al.
Japanese Journal of Clinical Oncology|April 1, 1997
Phase II study of ifosfamide and etoposide chemotherapy for extensive-disease small-cell lung cancerY M Chen, M F Wu, R P Perng, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|October 23, 1997
Restoration of the immunocompetence by IL-2 activation and TCR-CD3 engagement of the in vivo anergized tumor-specific CTL from lung cancer patientsY M Chen, W K Yang, J Whang-Peng, et al.
American Journal of Clinical Oncology|February 22, 2000
A phase II trial of vinorelbine and cisplatin in previously untreated inoperable non--small-cell lung cancerR P Perng, J F Shih, Y M Chen, et al.
British Journal of Cancer|March 1, 2002
Gemcitabine and cisplatin in a multimodality treatment for locally advanced non-small cell lung cancerC H Yang, C M Tsai, L S Wang, et al.
Pageof 16